522 related articles for article (PubMed ID: 29519249)
21. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
22. Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Carmina E; Lobo RA
J Womens Health (Larchmt); 2018 Nov; 27(11):1385-1388. PubMed ID: 30199308
[TBL] [Abstract][Full Text] [Related]
23. Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden.
Glintborg D; Ollila MM; Møller JK; Pesonen P; Persson S; Elenis E; Rubin KH; Gissler M; Andersen MS; Sundström-Poromaa I; Piltonen T
Hum Reprod; 2024 Jun; ():. PubMed ID: 38859639
[TBL] [Abstract][Full Text] [Related]
24. Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study.
Kluzek S; Rubin KH; Sanchez-Santos M; O'Hanlon MS; Andersen M; Glintborg D; Abrahamsen B
Arthritis Res Ther; 2021 Aug; 23(1):225. PubMed ID: 34461982
[TBL] [Abstract][Full Text] [Related]
25. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.
Sirmans SM; Weidman-Evans E; Everton V; Thompson D
Ann Pharmacother; 2012 Mar; 46(3):403-18. PubMed ID: 22388330
[TBL] [Abstract][Full Text] [Related]
26. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
Huang G; Coviello A
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):512-9. PubMed ID: 23108199
[TBL] [Abstract][Full Text] [Related]
27. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
28. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
Dwivedi AK; Vishwakarma D; Dubey P; Reddy S
Eur J Endocrinol; 2023 Jun; 188(6):555-563. PubMed ID: 37307574
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome.
Guleria AK; Syal SK; Kapoor A; Kumar S; Tiwari P; Dabadghao P
Gynecol Endocrinol; 2014 Jan; 30(1):26-9. PubMed ID: 24020937
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.
Wang ET; Calderon-Margalit R; Cedars MI; Daviglus ML; Merkin SS; Schreiner PJ; Sternfeld B; Wellons M; Schwartz SM; Lewis CE; Williams OD; Siscovick DS; Bibbins-Domingo K
Obstet Gynecol; 2011 Jan; 117(1):6-13. PubMed ID: 21173640
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
33. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular disease risk factors in polycystic ovary syndrome.
Dokras A
Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
[TBL] [Abstract][Full Text] [Related]
36. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome.
Joham AE; Kakoly NS; Teede HJ; Earnest A
J Clin Endocrinol Metab; 2021 May; 106(6):1585-1593. PubMed ID: 33693653
[TBL] [Abstract][Full Text] [Related]
39. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.
Kazemi Jaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Hosseinpanah F; Khalili D; Cheraghi L; Azizi F
Fertil Steril; 2017 Dec; 108(6):1078-1084. PubMed ID: 29202960
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
